Topical Pain Relief Market Analysis

The global topical pain relief market has been segmented on the basis of therapeutic class into opioids and non-opioids. The non-opioids segment is further sub-divided into non-steroidal anti-inflammatory drugs, lidocaine and others. The non-steroidal anti-inflammatory drugs segment with 54.31% share in the year 2036, occupies the largest market of topical pain relievers across the globe. Additionally, the non-steroidal anti-inflammatory drugs segment is anticipated to cross USD 6747.0 million by the end of 2028 by registering a CAGR of 4.21% over the forecast period. Further, the lidocaine segment is estimated to grow with the highest CAGR of 4.49% over the forecast period.

Our in-depth analysis of the global market includes the following segments: